STOCK TITAN

EWTX (NASDAQ: EWTX) holder to sell 180,872 stock shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

EWTX shareholder Robert Michael Carruthers has filed to sell 180,872 common shares through Morgan Stanley Smith Barney LLC on or about 01/15/2026 under Rule 144. The filing lists an aggregate market value of $4,804,322.06 for these shares, with 105,868,434 common shares of the issuer reported as outstanding.

The shares to be sold were acquired on 01/15/2026 by exercising options under a registered plan in two transactions of 166,665 and 14,207 shares, both paid in cash. Over the prior three months, Carruthers sold additional common shares in two transactions: 116,665 shares on 12/29/2025 for gross proceeds of $3,039,811.57 and 70,000 shares on 11/17/2025 for $1,566,586.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many EWTX shares does Robert Michael Carruthers plan to sell under this Form 144?

The notice states that 180,872 common shares of EWTX are proposed to be sold, with an aggregate market value of $4,804,322.06.

When are the EWTX shares expected to be sold and on which exchange?

The approximate sale date is listed as 01/15/2026, and the common shares are to be sold on the NASDAQ.

How were the EWTX shares being sold under this Form 144 acquired?

The filing shows the shares were acquired on 01/15/2026 through the exercise of options under a registered plan from the issuer, in amounts of 166,665 and 14,207 shares.

What prior EWTX share sales by this holder are disclosed in the last three months?

The holder sold 116,665 common shares on 12/29/2025 for $3,039,811.57 and 70,000 common shares on 11/17/2025 for $1,566,586.00.

How many EWTX shares are reported as outstanding in this Form 144 filing?

The securities information section reports 105,868,434 common shares of the issuer as outstanding.

Which broker is handling the planned EWTX share sale in this Form 144?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
Edgewise Therapeutics, Inc.

NASDAQ:EWTX

EWTX Rankings

EWTX Latest News

EWTX Latest SEC Filings

EWTX Stock Data

2.82B
85.98M
0.44%
116.32%
9.58%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOULDER